Local to global making a difference at Pierre Fabre
A family-run company overlaid with the corporate culture of a pharmaceutical multinational may sound like a tricky balancing act. But it can offer the best of both worlds
- Acoramidis approved for heart condition treatment
- Genomics study launches to optimise childhood cancer care in Ireland
- UCL researchers launch congenital muscular dystrophy research programme
- Novavax shares positive real-world results for JN.1-adapted COVID-19 vaccine
- FDA approves Click’s digital therapeutic for episodic migraine
